ChemoCentryx (NASDAQ:CCXI) also drew massive buying interest...
$ChemoCentryx(CCXI.US$ ChemoCentryx (NASDAQ:CCXI) also drew massive buying interest. Shares nearly doubled after the U.S. Food and Drug Administration approved its TAVNEOS drug.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment